Ikan Ikan Ikan
Skip to content
IKAN
  • About us
    • Who we are
    • Directors
    • Why zebrafish
    • Partners
  • Technology
  • Services
    • Drug Screening
    • Zebrafish Oncology Platform
    • Personalized Medicine
  • R&D
  • News Room
    • Videos
    • Articles
  • Contact
Menu
  • About us
    • Who we are
    • Directors
    • Why zebrafish
    • Partners
  • Technology
  • Services
    • Drug Screening
    • Zebrafish Oncology Platform
    • Personalized Medicine
  • R&D
  • News Room
    • Videos
    • Articles
  • Contact

New article published on Cancers – “Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study”

  • by globaladmin
  • April 1, 2022April 1, 2022

Zebrafish embryo tumor transplant models are widely utilized in cancer research. Compared with traditional murine models, the small size and transparency of zebrafish embryos combined… Read More »New article published on Cancers – “Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study”

Zebrafish Toxicity Assay as an in vivo model

  • by globaladmin
  • May 2, 2019April 1, 2022

Toxicity assay carry out in zebrafish The controversy surrounding the use of mammals in testing, associated with the problems and limitations inherent in its implementation,… Read More »Zebrafish Toxicity Assay as an in vivo model

Zebrafish: ideal tool for advancement in Biotechnology and Biomedicine

  • by globaladmin
  • March 26, 2019April 1, 2022

Why do we use zebrafish for human solutions? Even if it seems surprising, the reality is that zebrafish and human share high molecular and genetic… Read More »Zebrafish: ideal tool for advancement in Biotechnology and Biomedicine

Zebrafish: speeding Up the Cancer Drug Discovery Process

  • by globaladmin
  • December 12, 2018April 1, 2022

Read full publication on the following link: DOI:10.1158/0008-5472.CAN-18-1029

7th PREDiCT: Tumour Models London

  • by globaladmin
  • October 24, 2018April 1, 2022

London, UK  Wed, Dec 5, 2018 – Thu, Dec 6, 2018

Ikan Biotech has recently obtained the “Crédit Impôt Recherche (CIR)”

  • by globaladmin
  • October 9, 2018April 1, 2022

Ikan Biotech is now certified for “Crédit Impôt Recherche (CIR)” from The French Ministry of Higher Education, Research and Innovation of the Government of France. The CIR… Read More »Ikan Biotech has recently obtained the “Crédit Impôt Recherche (CIR)”

The Government of Navarra has allocated funding to strategic R&D projects.

  • by globaladmin
  • July 25, 2018April 1, 2022

Ikan Biotech will participate in strategic project “MINERVA”: a genomic study for personalizing the diagnosis and treatment of patients with chronic heart failure and chronic kidney disease.

Ikan Biotech is officially awarded Innovative SME stamp

  • by globaladmin
  • May 23, 2018April 1, 2022

The company Ikan Biotech has been officially recognized as INNOVATIVE SME by the Spanish Government and the Ministries of Economy and Competitiveness

Zebrafish: novel alternative tool in the scientific fight against cancer

  • by globaladmin
  • November 18, 2017April 1, 2022

The Zebrafish Lab uses zebrafish, cheaper and more effective than mice, to investigate new treatments

Contact us

Tell us about your needs

info@ikanbiotech.com

Email

+34 646 574 499

Phone

Mocholi Industrial Park, Plza. CEIN, 5 – A4
IKAN

QUALITY AND R&D POLICY    |    LEGAL NOTICE & PRIVACY POLICY    |    COOKIES POLICY

Linkedin Twitter Youtube
©2022, Ikan Biotech